Leiomyosarcoma of the cervix

Gynecologic Oncology

Volumn 91, Issue 3, 2003, Pages 636-642

  Irvin, William ^a   Presley, Ali ^a   Andersen, Willie ^a   Taylor, Peyton ^a   Rice, Laurel ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adjuvant therapy; Cervical leiomyosarcoma; Epithelioid leiomyosarcoma

Indexed keywords

ABDOMINAL HYSTERECTOMY; ABDOMINAL MASS; ADULT; ANAMNESIS; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LEIOMYOSARCOMA; MENORRHAGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SYMPTOM; TREATMENT OUTCOME; TUMOR LOCALIZATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VAGINA;

CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; UTERINE CERVICAL NEOPLASMS;

EID: 1642290690     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.08.037     Document Type: Article

References (40)

1. Sturday D.E. Leiomyosarcoma of the cervical stump following subtotal hysterectomy. Br J Surg. 46:1959;369-370.
2. Aaro L.A., Dockerty M.B. Leiomyosarcoma of the uterus. Am J Obstet Gynecol. 77:1959;1187-1198.
3. Blaustein A., Immerman B. Leiomyosarcoma of the cervix. Obstet Gynecol. 22:1963;224-227.
4. Abell M.R., Ramirez J.A. Sarcomas and carcinosarcoma of the uterine cervix. Cancer. 31:1973;1176-1192.
5. Rothbard M.J., Markham E.H. Leiomyosarcoma of the cervix report of a case. Am J Obstet Gynecol. 120:1974;853-854.
6. Jawalekar K.S., Zacharopoulou M., McCaffrey R.M. Leiomyosarcoma of the cervix uteri. South Med J. 74:1981;510-511.
7. Abdul-Karim F.W., Bazi T.M., Sorensen K., Nasr M.F. Sarcoma of the uterine cervix clinicopathologic findings in three cases. Gynecol Oncol. 26:1987;103-111.
8. David M.B., Dekel A., Gal R., Dicker D., Feldberg D., Goldman J.A. Prolapsed cervical leiomyosarcoma. Obstet Gynecol Surv. 43:1988;642-644.
9. Kasamatsu T., Shiromizu K., Takahashi M., Kikuchi A., Uehara T. Leiomyosarcoma of the uterine cervix. Gynecol Oncol. 69:1998;169-171.
10. Gotoh T., Kikuchi Y., Masashi T., Kita T., Ogata S., Aida S. Epithelioid leiomyosarcoma of the uterine cervix. Gynecol Oncol. 82:2001;400-405.
11. Taylor H.B., Norris H.J. Mesenchymal tumors of the uterus. Arch Pathol. 82:1966;40-44.
12. Hannigan E.V., Gomez L.G. Uterine leiomyosarcoma. Am J Obstet Gynecol. 134:1979;557-564.
13. Mayerhoffer K., Obermair A., Windbichler G., Petru E., Kaider A., Hefler L., Czerwenka K., Leodolter S., Kainz C. Leiomyosarcoma of the uterus a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 74:1999;196-201.
14. Berchuk A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Treatment of uterine leiomyosarcoma. Obstet Gynecol. 71:1988;845-850.
15. Gadducci A., Landoni F., Sartori E., Zola P., Maggino T., Lissoni A., Bazzurini L., Arisio R., Romagnolo C., Cristofani R. Uterine leiomyosarcoma analysis of treatment failures and survival. Gynecol Oncol. 62:1996;25-32.
16. Larson B., Silfversward C., Nilsson B., Pettersson F. Prognostic factors in uterine leiomyosarcoma a clinical and histopathological study of 143 cases. Acta Oncol. 29:1990;185-191.
17. Evans H.L., Chawla S.P., Simpson C., Finn K.P. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma a study of 46 cases with emphasis on diagnostic criteria and prognostic factors. Cancer. 62:1988;2239-2247.
18. Giuntoli R.L., Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., Gostout B.S. Retrospective review of 208 patients with leiomyosarcoma of the uterus prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 89:(3):2003;460-469.
19. Gard G.B., Mulvany M.J., Quinn M.A. Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol. 39:1999;93-98.
20. Goff B.A., Rice L.W., Fleischhacker H.G., Muntz H.G., Falkenberry S.S., Nikrui N., Fuller A.F. Uterine leiomyosarcoma and endometrial stromal sarcoma lymph node metastases and site of recurrence. Gynecol Oncol. 50:1993;105-109.
21. Weingrad D.N., Rosenberg S.A. Early lymphatic spread of osteogenic and soft-tissue sarcomas. Surgery. 84:1978;231-240.
22. Salazar O.M., Dunne M.E. The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Biol Phys. 6:1980;899-902.
23. Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasman W.T., Currie J.L., Yordan E., Brady M.F. Prognostic factors in early stage uterine sarcoma a Gynecologic Oncology Group study. Cancer. 71:1993;1702-1709.
24. Curtin J, Silverberg S, Thigpen J, Spanos W. Corpus: Mesenchymal tumors. In: Principles and practice of gynecologic oncology. New York: Lippincott-Raven; 1996: 912.
25. Thigpen J.T., Blessing J.A., Beecham J., Homesley H., Yordan E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas a Gynecologic Oncology Group study. J Clin Oncol. 9:1991;1962-1966.
26. Muss H.B., Bundy B.N., Adcock L., Beecham J. Mitoxantrone in the treatment of advanced uterine sarcoma. Am J Clin Oncol. 13:1984;3.
27. Asbury R., Blessing J.A., Buller R., Malfetano J.H., Walker J., Bernd-Uwe S. Amonifide in patients with leiomyosarcoma of the uterus. Am J Clin Oncol. 21:1998;145-156.
28. Rose P.G., Blessing J.A., Soper J.T., Barter J.F. Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus a gynecologic Oncology Group study. Gynecol Oncol. 70:1998;267-271.
29. Slayton R., Blessing J., Look K., Anderson B. A phase II clinical trial of diazoquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus a Gynecologic Oncology Group study. Invest New Drugs. 9:1991;207.
30. Sutton G.P., Blessing J.A., Barrett F.J., McGehee R. Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus a Gynecologic Oncology Group study. Am J Obstet Gynecol. 166:1992;556-559.
31. Slayton R., Blessing J., Ange C., Berman M. Phase II trial of etoposide in the management of advanced or recurrent leiomyosarcoma of the uterus a Gynecologic Oncology Group study. Cancer Treat Rep. 71:1987;1303.
32. Omura G.A., Major F.J., Blessing J.A., Sedlacek R.V., Thigpen J.T., Creasman W.T., Zaino R.T. A randomized study of adriamycin with and without dimethyl triazenolimidazole carboxamide in advanced uterine sarcomas. Cancer. 52:1983;626-632.
33. Sutton G., Blessing J.A., Ball H. Phase II trial of paclitaxel in leiomyosarcoma of the uterus a Gynecologic Oncology Group study. Gynecol Oncol. 74:(3):1999;364-369.
34. Currie J.L., Blessing J.A., Muss H.B., Fowler M.D., Berman M., Burke T.W. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma a Gynecologic Oncology Group study. Gynecol Oncol. 61:1996;27-30.
35. Sutton G., Blessing J.A., Malfetano J.H. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma of the uterus a Gynecologic Oncology Group study. Gynecol Oncol. 62:1996;226-229.
36. Georgoulias V., Kourousis C., Androulakis N., Kakloyris S.K., Dimopoulos M.A., Bouros D., Papadimiriou C., Hatzakis K., Heras P., Kalbakis K., Kotsakis T., Vardakis N., Mermveliotakis N., Hatzidaki D. Docetaxel and gemcitabine in the treatment of non-small cell lung cancer preliminary results. Semin Oncol. 24:1997;S14-22. S14-25.
37. Keshavarzi A., Vaezy S., Noble M., Chi E., Walker C., Martin R., Fujimoto V. Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound a potential treatment modality of recurrent pelvic disease. Gynecol Oncol. 86:2002;344-350.
38. Wu F., Chen W.Z., Bai J., Zou J.L., Wang Z.L., Zhu H., Wang Z.B. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 27:(8):2001;1099-1106.
39. Madersbacher S., Kratzik C., Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound histological impact and clinical application. Ultrason Sonochem. 4:(2):1997;175-179.
40. Gelet A., Chapelon J.Y., Bouvier R., Rouviere O., Lyonnet D., Dubernard J.M. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer factors influencing the outcome. Eur Urol. 40:(2):2001;124-129.